Abstract: Background: Graft-versus-host disease (GVHD) is a fatal complication of hematopoietic stem cell transplantation and is an enormous burden on the patient economy and related health systems. Nevertheless, only a few bibliometric studies have examined the direction of research and the major findings within the field.
Methods: Statistical and visualization bibliometric analysis was performed in April 2021. Our research data were retrieved from the Web of Science using an advanced search strategy. We then used bibliometric analysis to determine the current general research direction and trend of publications and established the most prolific and distinguished authors, institutions, countries, funding agencies, and keywords in GVHD research. We employed VOSviewer (Leiden University, Leiden, Netherlands), Microsoft Excel (Microsoft, Redmond, State of Washington), and GunnMap (https://lert.co.nz/map/) to retrieve, integrate, and visualize the results.
Results: Overall, 15,378 publications from 500 journals were extracted from the Institute for Scientific Information (ISI) Web of Science Core Collection database based on our analysis, of which the United States and the Fred Hutchinson Cancer Research Center were the most prolific countries and institutions, respectively. Moreover, we identified future research trends and the current status of GVHD research based on the top 10 most cited articles. Finally, influential authors' analysis demonstrated that Blazar, BR were both the most productive and most cited among all authors.
Conclusion: Our study provides an exhaustive and objective overview of the current status of GVHD research. This information would be highly beneficial to anyone seeking information on GVHD and would serve as a reference guide for researchers aiming to conduct further GVHD research.
Competing Interests: The authors have no conflicts of interest to disclose
(Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.)
References: Zeiser R, Blazar BR. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N Engl J Med. 2017;377:2565–79.
Ramachandran V, Kolli SS, Strowd LC. Review of graft-versus-host disease. Dermatol Clin. 2019;37:569–82.
Kernan NA, Collins NH, Juliano L, et al. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood. 1986;68:770–3.
Akinsheye I, Solovieff N, Ngo D, et al. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. Am J Hematol. 2012;87:217–9.
Molaro GL, De Angelis V. [Graft versus host disease after transfusion of blood and its products]. Riv Emoter Immunoematol. 1984;31:107–23.
Murali AR, Chandra S, Stewart Z, et al. Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management. Transplantation. 2016;100:2661–70.
Jagasia M, Arora M, Flowers ME, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296–307.
Carlens S, Ringdén O, Remberger M, et al. Risk factors for chronic graft versus host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998;22:755–61.
Atkinson K, Horowitz MM, Gale RP, et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood. 1990;75:2459–64.
Narli Özdemir Z, Şahin U, Dalva K, et al. Acute graft-versus-host disease: a brief review. Turk J Haematol. 2020;37:1–4.
Liu YM, Hockenberry M. Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective. J Pediatr Oncol Nurs. 2011;28:6–15.
Jain S, Basavaraj P, Singla A, et al. Bibliometric analysis of journal of clinical and diagnostic research (dentistry section; 2007-2014). J Clin Diagn Res. 2015;9:ZC47–51.
Kamdem JP, Duarte AE, Lima KRR, et al. Research trends in food chemistry: a bibliometric review of its 40 years anniversary (1976-2016). Food Chem. 2019;294:448–57.
Perianes-Rodriguez A, Waltman L, van Eck NJ. Constructing bibliometric networks: a comparison between full and fractional counting. J Informetr. 2016;10:1178–95.
Zyoud SH, Al-Jabi SW, Sweileh WM. Worldwide research productivity of paracetamol (acetaminophen) poisoning: a bibliometric analysis (2003-2012). Hum Exp Toxicol. 2015;34:12–23.
Patino-Barbosa AM, Bedoya-Arias JE, Cardona-Ospina JA, et al. Bibliometric assessment of the scientific production of literature regarding Mayaro. J Infect Public Health. 2016;9:532–4.
Yang W, Zhang J, Ma R. The prediction of infectious diseases: a bibliometric analysis. Int J Environ Res Public Health. 2020;17:6218.
Liu W, Hu G, Gu M. The probability of publishing in first-quartile journals. Scientometrics. 2015;106:1273–6.
Erfanmanesh M, Morovati M. Published errors and errata in library and information science journals. Collect Curation. 2019;38:61–7.
Fang C, Zhang J, Qiu W. Online classified advertising: a review and bibliometric analysis. Scientometrics. 2017;113:1481–511.
Gan C, Wang W. Research characteristics and status on social media in China: a bibliometric and co-word analysis. Scientometrics. 2015;105:1167–82.
Yang W, Liu Y, Zeng T, et al. Research focus and thematic trends in magnet hospital research: a bibliometric analysis of the global publications. J Adv Nurs. 2021;77:2012–25.
Su H-N, Lee P-C. Mapping knowledge structure by keyword co-occurrence: a first look at journal papers in technology foresight. Scientometrics. 2010;85:65–79.
Liu Z, Yin Y, Liu W, et al. Visualizing the intellectual structure and evolution of innovation systems research: a bibliometric analysis. Scientometrics. 2015;103:135–58.
Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: a scientometric update (2000 - 2014). Expert Opin Biol Ther. 2014;14:1295–317.
Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815–22.
Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097–100.
Jalali MS, Razak S, Gordon W, et al. Health care and cybersecurity: bibliometric analysis of the literature. J Med Internet Res. 2019;21:e12644.
Cheever MA, Einstein AB Jr, Kempf RA, et al. Reduction of fatal graft-versus-host disease by 3H-thymidine suicide of donor cells cultured with host cells. Transplantation. 1977;23:299–302.
Hill GR, Betts BC, Tkachev V, et al. Current concepts and advances in graft-versus-host disease immunology. Annu Rev Immunol. 2021;39:19–49.
Schoemans HM, Lee SJ, Ferrara JL, et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53:1401–15.
Zhao J, Yu G, Cai M, et al. Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus. Stem Cell Res Ther. 2018;9:32.
Nishimura H, Nose M, Hiai H, et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11:141–51.
Edinger M, Hoffmann P, Ermann J, et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9:1144–50.
Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–41.
Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–86.
Processing Request
No Comments.